{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:00:15Z","timestamp":1787022015580,"version":"build-2736575974"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Abramson Cancer Center"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188667","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T18:16:59Z","timestamp":1512065819000},"page":"e0188667","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Actionable mutations in canine hemangiosarcoma"],"prefix":"10.1371","volume":"12","author":[{"given":"Guannan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Maloneyhuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3442-0022","authenticated-orcid":true,"given":"David B.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8","article-title":"Prognostic factors in angiosarcoma: A multivariate analysis of 55 cases","volume":"61","author":"N Naka","year":"1996","journal-title":"J Surg Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2921","article-title":"Recurrent PTPRB and PLCG1 mutations in angiosarcoma","volume":"46","author":"S Behjati","year":"2014","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e5549","DOI":"10.1371\/journal.pone.0005549","article-title":"Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed","volume":"4","author":"BA Tamburini","year":"2009","journal-title":"PloS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/07357900009012210","article-title":"Spontaneously occurring tumors of companion animals as models for human cancer","volume":"18","author":"DM Vail","year":"2000","journal-title":"Cancer Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1354\/vp.42-5-618","article-title":"Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma","volume":"42","author":"EB Dickerson","year":"2005","journal-title":"Vet Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1746-6148-8-128","article-title":"Constitutive phosphorylation of the mTORC2\/Akt\/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines","volume":"8","author":"A Murai","year":"2012","journal-title":"BMC Vet Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cancergencyto.2007.07.017","article-title":"Mutation of the PTEN gene in a human hepatic angiosarcoma","volume":"178","author":"G Tate","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajpath.2013.12.025","article-title":"Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization","volume":"184","author":"BH Gorden","year":"2014","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10577-014-9406-z","article-title":"Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma","volume":"22","author":"R Thomas","year":"2014","journal-title":"Chromosome Res Int J Mol Supramol Evol Asp Chromosome Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e1004922","DOI":"10.1371\/journal.pgen.1004922","article-title":"Genome-wide Association Study Identifies Shared Risk Loci Common to Two Malignancies in Golden Retrievers","volume":"11","author":"N Tonomura","year":"2015","journal-title":"PLOS Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e0155189","DOI":"10.1371\/journal.pone.0155189","article-title":"Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines","volume":"11","author":"SD Martin","year":"2016","journal-title":"PLOS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"ZR Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1038\/modpathol.2013.176","article-title":"Malignant vascular tumors\u2014an update","volume":"27","author":"C Antonescu","year":"2014","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2164-9-201","article-title":"Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium","volume":"9","author":"C Ghilardi","year":"2008","journal-title":"BMC Genomics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"C Greenman","year":"2007","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pgen.1002344","article-title":"Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects","volume":"7","author":"TR Grossman","year":"2011","journal-title":"PLoS Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/7.2.227","article-title":"DSCAM: a novel member of the immunoglobulin superfamily maps in a Down syndrome region and is involved in the development of the nervous system","volume":"7","author":"K Yamakawa","year":"1998","journal-title":"Hum Mol Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","article-title":"Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity","volume":"45","author":"AM Dulak","year":"2013","journal-title":"Nat Genet"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003895","article-title":"Investigating the Structure and Dynamics of the PIK3CA Wild-Type and H1047R Oncogenic Mutant","volume":"10","author":"P Gkeka","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1073\/pnas.0510857103","article-title":"Cancer-specific mutations in PIK3CA are oncogenic in vivo","volume":"103","author":"AG Bader","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-017-0660-5","article-title":"PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models","volume":"16","author":"L Nisa","year":"2017","journal-title":"Mol Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccr.2005.05.014","article-title":"Mutant PIK3CA promotes cell growth and invasion of human cancer cells","volume":"7","author":"Y Samuels","year":"2005","journal-title":"Cancer Cell"},{"key":"ref23","first-page":"497","article-title":"PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma","volume":"6","author":"L Zhang","year":"2013","journal-title":"OncoTargets Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/0008-5472.CAN-12-1726","article-title":"PIK3CA mutation H1047R is associated with response to PI3K\/AKT\/mTOR signaling pathway inhibitors in early phase clinical trials","volume":"73","author":"F Janku","year":"2013","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1101\/gr.123109.111","article-title":"Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency","volume":"22","author":"L Wang","year":"2012","journal-title":"Genome Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","article-title":"Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy","volume":"4","author":"H Shi","year":"2014","journal-title":"Cancer Discov"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.201167798","article-title":"Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression","volume":"98","author":"B Kwabi-Addo","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","first-page":"547","article-title":"Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation","volume":"15","author":"CD James","year":"1999","journal-title":"Int J Oncol"},{"key":"ref30","article-title":"Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer","volume":"5","author":"J Chen","year":"2010","journal-title":"PLoS ONE"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11010-007-9503-9","article-title":"The over-expression of p53 H179Y residue mutation causes the increase of cyclin A1 and Cdk4 expression in HELF cells","volume":"304","author":"D Yang","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neo.2015.10.003","article-title":"Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival","volume":"17","author":"LK Mullany","year":"2015","journal-title":"Neoplasia N Y N"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/onc.2009.376","article-title":"A common Gain of function of p53 cancer mutants in inducing genetic instability","volume":"29","author":"D Liu","year":"2010","journal-title":"Oncogene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ncb1571","article-title":"p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM","volume":"9","author":"H Song","year":"2007","journal-title":"Nat Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3324\/haematol.2014.113696","article-title":"Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas","volume":"100","author":"R Manso","year":"2015","journal-title":"Haematologica"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2013-05-504308","article-title":"PLCG1 mutations in cutaneous T-cell lymphomas","volume":"123","author":"JP Vaqu\u00e9","year":"2014","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/PAS.0000000000000582","article-title":"Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations","volume":"40","author":"S-C Huang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1746-6148-8-128","article-title":"Constitutive phosphorylation of the mTORC2\/Akt\/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines","volume":"8","author":"A Murai","year":"2012","journal-title":"BMC Vet Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jcpa.2012.05.002","article-title":"Immunohistochemical analysis of the Akt\/mTOR\/4E-BP1 signalling pathway in canine haemangiomas and haemangiosarcomas","volume":"147","author":"A Murai","year":"2012","journal-title":"J Comp Pathol"},{"key":"ref40","first-page":"209","article-title":"Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines","volume":"80","author":"M Adachi","year":"2016","journal-title":"Can J Vet Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3892\/ijo.2015.2989","article-title":"Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts","volume":"47","author":"NJ ANDERSEN","year":"2015","journal-title":"Int J Oncol"},{"key":"ref42","unstructured":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.\u2014PubMed\u2014NCBI [Internet]. [cited 8 Sep 2017]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22658544\" xlink:type=\"simple\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22658544<\/ext-link>"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e0123092","DOI":"10.1371\/journal.pone.0123092","article-title":"Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K\/AKT\/mTOR Signaling and Sensitivity to PIK3 Inhibitors","volume":"10","author":"DC Loconte","year":"2015","journal-title":"PloS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ajmg.c.31531","article-title":"Somatic overgrowth disorders of the PI3K\/AKT\/mTOR pathway &amp; therapeutic strategies","volume":"172","author":"KM Keppler-Noreuil","year":"2016","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"36041","DOI":"10.18632\/oncotarget.5936","article-title":"Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway","volume":"6","author":"R Murali","year":"2015","journal-title":"Oncotarget"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<952::AID-IJC7>3.0.CO;2-X","article-title":"Mutations of p53 tumor-suppressor gene in angiosarcoma","volume":"71","author":"N Naka","year":"1997","journal-title":"Int J Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1002\/cncr.27614","article-title":"Alterations of the p53 and PIK3CA\/AKT\/mTOR pathways in angiosarcomas","volume":"118","author":"A Italiano","year":"2012","journal-title":"Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T01:57:22Z","timestamp":1570413442000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188667"}},"subtitle":[],"editor":[{"given":"Amanda Ewart","family":"Toland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188667","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]}}}